{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:41:29Z","timestamp":1759624889295,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.clineuro.2020.106347","type":"journal-article","created":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T23:52:10Z","timestamp":1604274730000},"page":"106347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Prediction of CTNNB1 Mutation Status in Pediatric Cystic Adamantinomatous Craniopharyngioma by Using Preoperative Magnetic Resonance Imaging Manifestation"],"prefix":"10.1016","volume":"200","author":[{"given":"Wanchun","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianchi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bowen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6106-8891","authenticated-orcid":false,"given":"Shiting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9869-4036","authenticated-orcid":false,"given":"Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2020.106347_bib0005","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/s00381-005-1181-x","article-title":"Epidemiology of pediatric tumors of the nervous system according to the WHO 2000 classification: a report of 1,195 cases from a single institution","volume":"21","author":"Rosemberg","year":"2005","journal-title":"Childs Nerv Syst"},{"issue":"2","key":"10.1016\/j.clineuro.2020.106347_bib0010","first-page":"178","article-title":"Comparative effectiveness of treatment options for pediatric craniopharyngiomas","volume":"13","author":"Ali","year":"2014","journal-title":"J Neuros: Pediatr"},{"issue":"4","key":"10.1016\/j.clineuro.2020.106347_bib0015","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.3171\/2010.2.FOCUS09318","article-title":"Craniopharyngioma and other cystic epithelial lesions of the sellar region: a review of clinical, imaging, and histopathological relationships","volume":"28","author":"Zada","year":"2010","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.clineuro.2020.106347_bib0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000357783","article-title":"Patterns of care for craniopharyngioma: survey of members of the American Association of Neurological Surgeons","volume":"49","author":"Hankinson","year":"2013","journal-title":"Pediatr Neurosurg"},{"key":"10.1016\/j.clineuro.2020.106347_bib0025","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00381-019-04178-0","article-title":"Prediction of calcification tendency in pediatric cystic adamantinomatous craniopharyngioma by using inflammatory markers, hormone markers, and radiological appearances","volume":"35","author":"Chen","year":"2019","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.clineuro.2020.106347_bib0030","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.clineuro.2020.106347_bib0035","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","article-title":"Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations","volume":"367","author":"Flaherty","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clineuro.2020.106347_bib0040","first-page":"2744","article-title":"Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells","volume":"62","author":"Kim","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.clineuro.2020.106347_bib0045","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1750-3639.2008.00180.x","article-title":"Target gene activation of the Wnt signaling pathway in nuclear beta-catenin accumulating cells of adamantinomatous craniopharyngiomas","volume":"19","author":"H\u00f6lsken","year":"2009","journal-title":"Brain Pathol"},{"key":"10.1016\/j.clineuro.2020.106347_bib0050","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng.2868","article-title":"Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas","volume":"46","author":"Brastianos","year":"2014","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.clineuro.2020.106347_bib0055","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3171\/2016.9.FOCUS16308","article-title":"Potential evolution of neurosurgical treatment paradigms for craniopharyngioma based on genomic and transcriptomic characteristics","volume":"41","author":"Robinson","year":"2016","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.clineuro.2020.106347_bib0060","first-page":"1849","article-title":"PROP1 and CTNNB1 expression in adamantinomatous craniopharyngiomas with or without beta-catenin mutations","volume":"66","author":"Cani","year":"2011","journal-title":"Clinics (S\u00e3o Paulo)"},{"issue":"3","key":"10.1016\/j.clineuro.2020.106347_bib0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11060-004-5232-z","article-title":"\u03b2-catenin mutations in craniopharyngiomas and pituitary adenomas","volume":"73","author":"Oikonomou","year":"2005","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.clineuro.2020.106347_bib0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3171\/jns.1992.76.1.0047","article-title":"Aggressive surgical management of craniopharyngiomas in children","volume":"76","author":"Hoffman","year":"1992","journal-title":"J Neurosurg"},{"key":"10.1016\/j.clineuro.2020.106347_bib0075","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3171\/2018.3.JNS172528","article-title":"Clinical and biological significance of adamantinomatous craniopharyngioma with CTNNB1 mutation","volume":"131","author":"Takuma","year":"2019","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.clineuro.2020.106347_bib0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3171\/jns.1999.90.2.0237","article-title":"Surgical treatment of craniopharyngiomas: experience with 168 patients","volume":"90","author":"Fahlbusch","year":"1999","journal-title":"J Neurosurg"},{"issue":"Suppl 1","key":"10.1016\/j.clineuro.2020.106347_bib0085","first-page":"9","volume":"57","author":"Committee of the Brain Tumor Registry of Japan: Brain Tumor Registry of Japan: (2005-2008) 14th edition","year":"2017","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.clineuro.2020.106347_bib0090","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/S0002-9440(10)64477-X","article-title":"Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations","volume":"161","author":"Sekine","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clineuro.2020.106347_bib0095","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00401-010-0642-9","article-title":"Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling","volume":"119","author":"H\u00f6lsken","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.clineuro.2020.106347_bib0100","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00401-005-1004-x","article-title":"Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region","volume":"109","author":"Buslei","year":"2005","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.clineuro.2020.106347_bib0105","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/path.1562","article-title":"Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma","volume":"203","author":"Kato","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.clineuro.2020.106347_bib0110","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00381-017-3473-3","article-title":"A reformed surgical treatment modality for children with giant cystic craniopharyngioma","volume":"33","author":"Zhu","year":"2017","journal-title":"Childs Nerv Syst"},{"issue":"1","key":"10.1016\/j.clineuro.2020.106347_bib0115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12883-018-1216-z","article-title":"Noninvasive molecular diagnosis of craniopharyngioma with MRI-based radiomics approach","volume":"19","author":"Chen","year":"2019","journal-title":"BMC Neurology"},{"issue":"1","key":"10.1016\/j.clineuro.2020.106347_bib0120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41572-019-0125-9","article-title":"Craniopharyngioma","volume":"5","author":"M\u00fcller","year":"2019","journal-title":"Nature Reviews Disease Primers"},{"key":"10.1016\/j.clineuro.2020.106347_bib0125","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1128\/MCB.22.4.1172-1183.2002","article-title":"Wnt\/beta-catenin\/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway","volume":"22","author":"Jho","year":"2002","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.clineuro.2020.106347_bib0130","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13048-019-0596-z","article-title":"Wnt\/\u03b2-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis","volume":"12","author":"Nguyen","year":"2019","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.clineuro.2020.106347_bib0135","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/mc.22304","article-title":"miR-577 inhibits glioblastoma tumor growth via the Wnt signaling pathway","volume":"55","author":"Zhang","year":"2016","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.clineuro.2020.106347_bib0140","first-page":"587","article-title":"Molecular genetics and targeted therapy of WNT-related human diseases (Review)","volume":"40","author":"Katoh","year":"2017","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.clineuro.2020.106347_bib0145","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0002-9440(10)63528-6","article-title":"\u03b2-catenin mutations are frequent in calcifying odontogenic cysts, but rare in ameloblastomas","volume":"163","author":"Sekine","year":"2003","journal-title":"Am J Pathol"},{"issue":"28","key":"10.1016\/j.clineuro.2020.106347_bib0150","doi-asserted-by":"crossref","first-page":"25390","DOI":"10.18632\/oncotarget.4455","article-title":"Tankyrase inhibitors attenuate WNT\/ \u03b2-catenin signaling and inhibit growth of hepatocellular carcinoma cells","volume":"6","author":"Ma","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.clineuro.2020.106347_bib0155","doi-asserted-by":"crossref","DOI":"10.1007\/s00408-020-00324-7","article-title":"High Expression of CARM1 Inhibits Lung Cancer Progression by Targeting TP53 by Regulating CTNNB1","author":"Hu","year":"2020","journal-title":"Lung"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720306909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720306909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:36:02Z","timestamp":1759588562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846720306909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":31,"alternative-id":["S0303846720306909"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.106347","relation":{},"ISSN":["0303-8467"],"issn-type":[{"type":"print","value":"0303-8467"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of CTNNB1 Mutation Status in Pediatric Cystic Adamantinomatous Craniopharyngioma by Using Preoperative Magnetic Resonance Imaging Manifestation","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.106347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106347"}}